JP2022536223A - ニーム抽出物並びにウロリチンａ及びｂの相乗作用組み合わせの抗糖尿病活性 - Google Patents

ニーム抽出物並びにウロリチンａ及びｂの相乗作用組み合わせの抗糖尿病活性 Download PDF

Info

Publication number
JP2022536223A
JP2022536223A JP2021524012A JP2021524012A JP2022536223A JP 2022536223 A JP2022536223 A JP 2022536223A JP 2021524012 A JP2021524012 A JP 2021524012A JP 2021524012 A JP2021524012 A JP 2021524012A JP 2022536223 A JP2022536223 A JP 2022536223A
Authority
JP
Japan
Prior art keywords
aqueous extract
azadirachta indica
weeks
neem
individual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021524012A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022536223A5 (https=
JPWO2020097014A5 (https=
Inventor
ヴィーララガヴァン，ムルガナンダム，エイ．
セン，チャンダン，ケイ．
カリディンディ，サニャーシ，アール．
Original Assignee
ナトレオン，インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ナトレオン，インコーポレイテッド filed Critical ナトレオン，インコーポレイテッド
Publication of JP2022536223A publication Critical patent/JP2022536223A/ja
Publication of JP2022536223A5 publication Critical patent/JP2022536223A5/ja
Publication of JPWO2020097014A5 publication Critical patent/JPWO2020097014A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2021524012A 2018-11-05 2019-11-05 ニーム抽出物並びにウロリチンａ及びｂの相乗作用組み合わせの抗糖尿病活性 Pending JP2022536223A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201841041788 2018-11-05
PCT/US2019/059774 WO2020097014A1 (en) 2018-11-05 2019-11-05 Anti-diabetic activity of neem extract and synergistic combinations of urolithins a and b

Publications (3)

Publication Number Publication Date
JP2022536223A true JP2022536223A (ja) 2022-08-15
JP2022536223A5 JP2022536223A5 (https=) 2022-09-05
JPWO2020097014A5 JPWO2020097014A5 (https=) 2022-09-05

Family

ID=70460249

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021524012A Pending JP2022536223A (ja) 2018-11-05 2019-11-05 ニーム抽出物並びにウロリチンａ及びｂの相乗作用組み合わせの抗糖尿病活性

Country Status (10)

Country Link
US (1) US20200138892A1 (https=)
EP (1) EP3876968A4 (https=)
JP (1) JP2022536223A (https=)
KR (1) KR20210096121A (https=)
CN (1) CN113226347A (https=)
AU (1) AU2019377432A1 (https=)
BR (1) BR112021008725A2 (https=)
CA (1) CA3118926A1 (https=)
MX (1) MX2021005246A (https=)
WO (1) WO2020097014A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220098228A1 (en) * 2020-09-28 2022-03-31 Natreon, Inc. Methods and compositions for improving the immune system and providing immuno-protection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8206753B2 (en) * 2001-06-20 2012-06-26 Metaproteomics, Llc Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
JP2005325025A (ja) * 2004-05-12 2005-11-24 Green Kanpo Seiyaku Kk 糖尿病予防・治療組成物
WO2006030426A1 (en) * 2004-09-13 2006-03-23 Amcod Limited Herbal compositions for treatment of diabetes

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF AYURVEDA AND INTEGRATIVE MEDICINE, vol. 6, no. 3, JPN6023021618, 2015, pages 165 - 174, ISSN: 0005255050 *
JOURNAL OF NATURAL REMEDIES, vol. Vol. 6/2, JPN6023021617, 2006, pages 109 - 114, ISSN: 0005255051 *
PRATIBHA KALANI; ET AL: "EFFECT OF TRIGONELLA FOENUM-GRAECUM (METHI) AND AZADIRACHTA INDICA (NEEM) AS AN 以下備考", WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, vol. VOL:6, NR:1, JPN5022002494, 2017, pages 1247 - 1258, ISSN: 0005255049 *

Also Published As

Publication number Publication date
EP3876968A4 (en) 2022-09-14
WO2020097014A1 (en) 2020-05-14
US20200138892A1 (en) 2020-05-07
BR112021008725A2 (pt) 2021-08-03
CA3118926A1 (en) 2020-05-14
KR20210096121A (ko) 2021-08-04
EP3876968A1 (en) 2021-09-15
AU2019377432A1 (en) 2021-06-10
CN113226347A (zh) 2021-08-06
MX2021005246A (es) 2021-09-08

Similar Documents

Publication Publication Date Title
Kianbakht et al. Improved glycemic control in patients with advanced type 2 diabetes mellitus taking Urtica dioica leaf extract: a randomized double-blind placebo-controlled clinical trial
JP2021525709A (ja) 自閉症スペクトラム障害の治療のためのカンナビスベースの組成物
US20120093942A1 (en) Pharmaceutical composition for treating nephropathy and healthy food comprising herb extracts
Majeed et al. Novel Emblica officinalis extract containing β-glucogallin vs. metformin: a randomized, open-label, comparative efficacy study in newly diagnosed type 2 diabetes mellitus patients with dyslipidemia
Widyawati et al. Effect of bay leaf ethanol extract on blood glucose level in patients with type 2 diabetes mellitus
Sakhaei et al. Cardiovascular and renal effects of Hibiscus Sabdariffa Linnaeus. in patients with diabetic nephropathy: A randomized, double-blind, controlled trial
CN116919931A (zh) 烟草提取物在制备预防和/或治疗糖尿病药物中的应用
US10183047B2 (en) Chromium-containing compositions in combination with Phyllanthus emblica and shilajit having synergistic effects for improving endothelial function and cardiovascular health
JP2022536223A (ja) ニーム抽出物並びにウロリチンａ及びｂの相乗作用組み合わせの抗糖尿病活性
EP4161550A1 (en) Shan-zha for the treatment of depression and anxiety disorders
Farag et al. The role of medicinal plants in the treatment of type-2 diabetes
Haider et al. Efficacy and safety of Plantago major seeds in patients with diabetic nephropathy: A randomized open-labeled controlled clinical trial
US20160015740A1 (en) Chromium-containing compositions for improving endothelial function and cardiovascular health
KR101732483B1 (ko) 연교 추출물을 유효성분으로 함유하는 말초신경병증 예방, 개선 또는 치료용 조성물
Agnes Exploring the nutritional benefits of medicinal plants in diabetes management
RU2238755C1 (ru) Лечебно-профилактическое средство, обладающее гепатопротекторным, холестерино- и сахарорегулирующим действием (варианты)
Savona-Ventura Fenugreek: a natural prototype oral hypoglycaemic agent used in Malta
US9278081B2 (en) Extracts from Eucalyptus camaldulensis for the treatment of hyperglycemia and hypertension
Basuny et al. Efficacy of the traditional use of Olive Leaves decoction as Anti-diabetic Agent in Geriatrics.
KR20040092232A (ko) 성기능 개선용 홍삼복합물, 이의 제조방법 및 이의 용도
RU2805492C9 (ru) Способ коррекции постпрандиальной гликемии
WO2016186695A1 (en) Synergistic compositions containing chromium with phyllanthus emblica and shilajit for improving endothelial function and cardiovascular health
KR102266256B1 (ko) 황기 추출물 및 지치 추출물을 유효성분으로 포함하는 항당뇨용 약학적 조성물
McLean Reviews of articles on medicinal herbs
Dilawar et al. Management of Shvitra (Vitiligo) By An Ayurvedic Regime-A Case Study

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220826

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220826

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230530

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230531

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230828

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20231024

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20240206